SARAH TERAMAE: Open Payments
NPI 1720793235 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $114 |
| Boston Scientific Corporation | 2 | $50 |
| IMMUNITYBIO, INC. | 1 | $33 |
| Dendreon Pharmaceuticals LLC | 1 | $30 |
| Procept Biorobotics Corporation | 1 | $29 |
| UROGEN PHARMA, INC. | 1 | $25 |
| COLOPLAST CORP | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| AngioDynamics, Inc. | 1 | $20 |
Products named: BOTOX, AMS 700, ANKTIVA, PROVENGE, AQUABEAM ROBOTIC SYSTEM, Luja Coude, GEMTESA, NANOKNIFE.
Industry payments across CA — which companies pay providers there.
